UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

The New England journal of medicine, 2018-12, Vol.379 (23), p.2220-2229

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (22), p.2965-2971

2011

Link zum Volltext

Verfügbarkeit prüfen

Ceritinib in second and further lines of therapy in advanced ALK mutant adenocarcinoma

Journal of thoracic disease, 2016-07, Vol.8 (7), p.E584-E585

Losonczy, György

2016

Link zum Volltext

Verfügbarkeit prüfen

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

Respiratory research, 2019-07, Vol.20 (1), p.156-156, Article 156

2019

Link zum Volltext

Verfügbarkeit prüfen

The link between the sphingolipid rheostat and obstructive sleep apnea

Scientific reports, 2023-05, Vol.13 (1), p.7675-7675, Article 7675

2023

Link zum Volltext

Verfügbarkeit prüfen

Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses

ERJ open research, 2021-01, Vol.7 (1), p.543

2021

Link zum Volltext

Verfügbarkeit prüfen

Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease

Journal of breath research, 2018-05, Vol.12 (3), p.036017-036017

2018

Link zum Volltext

Verfügbarkeit prüfen

Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies

Cell stress & chaperones, 2010-05, Vol.15 (3), p.237-247

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report

JTO clinical and research reports, 2022-06, Vol.3 (6), p.100330-100330, Article 100330

2022

Link zum Volltext

Verfügbarkeit prüfen

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

BMC pulmonary medicine, 2011-07, Vol.11 (1), p.40-40, Article 40

2011

Link zum Volltext

Verfügbarkeit prüfen

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

The lancet oncology, 2015-03, Vol.16 (3), p.328-337

2015

Link zum Volltext

Verfügbarkeit prüfen

P192: Endothelial Dysfunction, Arterial Stiffness in Lung Transplanted Individuals

Artery research, 2017-12, Vol.20 (1), p.109-109

2017

Link zum Volltext

Verfügbarkeit prüfen

Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure

The European respiratory journal, 2017-02, Vol.49 (2), p.1601270-1601270

2017

Link zum Volltext

Verfügbarkeit prüfen

Galectin-9 in Allergic Airway Inflammation and Hyper-Responsiveness in Mice

International archives of allergy and immunology, 2010-01, Vol.151 (4), p.308-317

2010

Link zum Volltext

Verfügbarkeit prüfen

Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2024-06, Vol.192, p.107824-107824, Article 107824

2024

Link zum Volltext

Verfügbarkeit prüfen

Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL-10–producing immature transitional regulatory B cells

Journal of allergy and clinical immunology, 2018-07, Vol.142 (1), p.178-194.e11

2018

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol induces mitochondrial biogenesis in endothelial cells

American journal of physiology. Heart and circulatory physiology, 2009-07, Vol.297 (1), p.H13-H20

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2018-06, Vol.23 (6), p.654-e58

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer

Pathology oncology research, 2020-04, Vol.26 (2), p.1117-1128

2020

Link zum Volltext

Verfügbarkeit prüfen

A suitable protocol for measuring alveolar nitric oxide in asthma with differing severity to assess peripheral airways inflammation

The Journal of asthma, 2019-06, Vol.56 (6), p.584-593

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107418-107418, Article 107418

2023

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in the disease

International immunology, 2009-08, Vol.21 (8), p.967-975

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(157)

Publikationsform

Artikel
(190)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Ceritinib in second and further lines of therapy in advanced ALK mutant adenocarcinoma

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

The link between the sphingolipid rheostat and obstructive sleep apnea

Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses

Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies

Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

P192: Endothelial Dysfunction, Arterial Stiffness in Lung Transplanted Individuals

Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure

Galectin-9 in Allergic Airway Inflammation and Hyper-Responsiveness in Mice

Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma

Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL-10–producing immature transitional regulatory B cells

Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study

Resveratrol induces mitochondrial biogenesis in endothelial cells

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer

Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer

A suitable protocol for measuring alveolar nitric oxide in asthma with differing severity to assess peripheral airways inflammation

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in the disease

Suchergebnisse filtern